Author:
Chakrabarti S,McDonald D,Milligan DW
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference6 articles.
1. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative toconventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756–763
2. Giralt S, Thall PF, Khouri I et al. Melphalan and purineanalog-containing preparative regimens: reduced-intensityconditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation Blood 2001 97: 631–637
3. Kottaridis PD, Milligan DW, Chopra R et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation Blood 2000 96: 2419–2425
4. Chakrabarti S, Kottaridis P, Ogormon P et al. High incidence of early and late CMV infection and delayed immune reconstitution after allogeneic transplants with nonmyeloablative conditioning using Campath (anti-CD52 antibody) Blood 2000 96: 525a (Abstr.)
5. Craddock C, Bardy P, Kreiter S et al. Engraftment of T cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen Br J Haematol 2000 111: 797–800
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献